Strategic Focus Target Latin America and diaspora populations with precision health capabilities, offering polygenic risk assessment and diagnostic acceleration services to research institutions, biobanks, and healthcare providers seeking diverse genomic data.

Partnership Potential Leverage recent collaborations with Fabric Genomics to co-develop clinical reporting workflows and gene panel curation, proposing integrated solutions for customers requiring end-to-end genomics informatics and PRS integration.

Growth Financing Capitalize on recent $25M funding to support platform expansion, additional datasets, and go-to-market efforts for StrataRisk SaaS, presenting enterprise pricing, governance options, and scalable cloud-based delivery to health systems and CROs.

Product Differentiation Position StrataRisk as a scalable, climate- and population-aware PRS platform for common diseases (cardiovascular, metabolic, cancer) with emphasis on diverse cohorts, enabling customers to deliver personalized risk reports at point-of-care or research settings.

Data & Trust Highlight the community-owned biobank model and data-use governance as a selling point for partners prioritizing ethical data sharing, patient engagement, and long-term collaboration with researchers, clinicians, and patient families.